Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World: Evaluating the Effect of a Skinny Label, Implications of GSK v. Teva

Marbury Partner Michelle O’Brien and Senior Partner, Tom Irving, will be participating on a panel in the Strafford webinar entitled “Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World: Evaluating the Effect of a Skinny Label, Implications of GSK v. Teva”. Michelle and Tom will be discussing the following cases: Amarin Pharma v. Hikma Pharms. USA Inc., No. 20-1630 (D. [...]